MA28177A1 - 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate ou tosylate en tant qu'agents antipsychotiques - Google Patents

7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate ou tosylate en tant qu'agents antipsychotiques

Info

Publication number
MA28177A1
MA28177A1 MA29055A MA29055A MA28177A1 MA 28177 A1 MA28177 A1 MA 28177A1 MA 29055 A MA29055 A MA 29055A MA 29055 A MA29055 A MA 29055A MA 28177 A1 MA28177 A1 MA 28177A1
Authority
MA
Morocco
Prior art keywords
chlorobenzyloxy
benzenesulfonyl
tosylate
tetrahydro
methoxy
Prior art date
Application number
MA29055A
Other languages
English (en)
Inventor
David Clapham
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA28177A1 publication Critical patent/MA28177A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
MA29055A 2003-11-28 2006-05-24 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate ou tosylate en tant qu'agents antipsychotiques MA28177A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0327740.7A GB0327740D0 (en) 2003-11-28 2003-11-28 Novel compounds

Publications (1)

Publication Number Publication Date
MA28177A1 true MA28177A1 (fr) 2006-09-01

Family

ID=29798028

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29055A MA28177A1 (fr) 2003-11-28 2006-05-24 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate ou tosylate en tant qu'agents antipsychotiques

Country Status (18)

Country Link
US (1) US20070275948A1 (fr)
EP (1) EP1687279A1 (fr)
JP (1) JP2007512285A (fr)
KR (1) KR20060103322A (fr)
CN (1) CN1906170A (fr)
AR (1) AR046719A1 (fr)
AU (1) AU2004293179A1 (fr)
BR (1) BRPI0417029A (fr)
CA (1) CA2547444A1 (fr)
GB (1) GB0327740D0 (fr)
IL (1) IL175663A0 (fr)
IS (1) IS8500A (fr)
MA (1) MA28177A1 (fr)
NO (1) NO20062970L (fr)
RU (1) RU2006122959A (fr)
TW (1) TW200528433A (fr)
WO (1) WO2005051916A1 (fr)
ZA (1) ZA200603781B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0510599D0 (en) * 2005-05-24 2005-06-29 Glaxo Group Ltd Novel compounds
GB0603087D0 (en) * 2006-02-15 2006-03-29 Glaxo Group Ltd Novel use
AU2009203598B2 (en) * 2008-01-08 2013-09-26 Merck Sharp & Dohme Llc Pharmaceutically acceptable salts of 2-{4-[(3S)-piperidin-3- yl]phenyl} -2H-indazole-7-carboxamide
US20180228811A1 (en) * 2014-12-12 2018-08-16 The Schepens Eye Research Institute, Inc. Gdnf induction for the treatment of retinal disorders
BR112019016775A2 (pt) 2017-02-17 2020-03-31 Trevena, Inc. Compostos moduladores de receptor delta-opioide contendo aza-heterocíclico com 7 membros, métodos de uso e produção dos mesmos
JP2023546729A (ja) * 2020-10-27 2023-11-07 トレベナ・インコーポレイテッド デルタオピオイドモジュレーターの結晶形及び非晶形
CN115998724B (zh) * 2023-03-28 2023-06-16 中国人民解放军军事科学院军事医学研究院 布洛芬在抗幻觉作用药物中的新用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003062205A1 (fr) * 2001-12-21 2003-07-31 Smithkline Beecham P.L.C. Derives de 7-sulfonyl-3-benzazepine utilises comme modulateurs du recepteur a la dopamine et utilisation de ces derniers dans le traitement des troubles du systeme nerveux central
WO2003068752A1 (fr) * 2002-02-13 2003-08-21 Glaxo Group Limited Derives benzenesulfonamide utilises comme antipsychotiques
MY133587A (en) * 2002-05-29 2007-11-30 Glaxo Group Ltd Aromatic sulfones and their medical use

Also Published As

Publication number Publication date
IL175663A0 (en) 2006-09-05
WO2005051916A1 (fr) 2005-06-09
BRPI0417029A (pt) 2007-02-06
IS8500A (is) 2006-06-08
TW200528433A (en) 2005-09-01
KR20060103322A (ko) 2006-09-28
NO20062970L (no) 2006-08-21
JP2007512285A (ja) 2007-05-17
RU2006122959A (ru) 2008-01-10
CN1906170A (zh) 2007-01-31
EP1687279A1 (fr) 2006-08-09
AR046719A1 (es) 2005-12-21
US20070275948A1 (en) 2007-11-29
CA2547444A1 (fr) 2005-06-09
AU2004293179A1 (en) 2005-06-09
ZA200603781B (en) 2007-09-26
GB0327740D0 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
FR17C0008I1 (fr) Derives de (thio) carbamoyl-cyclohexane utilises en tant qu'antagonistes des recepteurs d3/d2
MA28177A1 (fr) 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate ou tosylate en tant qu'agents antipsychotiques
PT1381363E (pt) Derivados de imidazo-(1,2-a)-piridina como antagonistas mglur5
DE60218340D1 (de) 5,6-diaryl-pyrazineamidderivate als cb1 antagonisten
FR17C1013I2 (fr) Pyrrolo[2,3-b]pyridines et pyrrolo[2,3-b]pyrimidines a substitution heteroaryle en tant qu'inhibiteurs de la janus kinase
ATE299868T1 (de) Dihydro-benzo (b) (1,4) diazepin-2-on-derivate als mglur2 antagonisten
ATE461191T1 (de) N-substituierte 2-oxodihydropyridinderivate als npy antagonisten
DE60214428D1 (de) 1, 4-dihydro-1, 4-diphenylpyridin-derivate
NO20041235L (no) Kinolinderivater som neuropeptid Y antagonister
ATE287883T1 (de) Dihydro-benzo(b)(1,4)diazepin-2-on-derivate als mglur2 antagonisten
NO20023485L (no) 1,3-disubstituerte pyrrolidiner som alfa-2- adrenoceptorantagonister
DE60110844D1 (de) Chinazolone derivate als alfa 1a/b adrenozeptor antagonisten
DE60320529D1 (de) Chinolinderivate als npy antagonisten
ATE259363T1 (de) Piperazinderivate als 5-ht1b antagonisten
MA26958A1 (fr) Derives de 2-phenylaminoimidazoline phenyl cetone substituee en tant qu'antagonistes ip
MA27046A1 (fr) Nouveaux derives d'oxazolidinones en tant qu'agents antibacteriens.
FR2813756B1 (fr) Dilueur pour la conservation de spermatozoides de porcins
NO20043794L (no) Benzensulfonamidderivater som antipsykotiske midler
MA28602B1 (fr) Pyridin-4-yl-ethynyl-imidazoles et pyrazoles en tant qu'antagonistes des recepteurs mglur5
DE60207399D1 (de) Alkoxycarbonylaminobenzoesäure- oder alkoxycarbonylaminotetrazolylphenylderivate als ip-antagonisten
ATE492535T1 (de) 4-piperidinylalkylamin-derivate, antagonisten von muscarinrezeptoren
DE602006008937D1 (de) N-amidderivate von 8-azabicycloä3.2.1üoct-3-yl als ccr1-antagonisten
DE60017110D1 (de) Biphenylderivate als neurokinin-1 antagonisten
ATE418542T1 (de) Als ccr5-antagonisten verwendbare aryloxim- piperazine
FR2837697B1 (fr) Composition cosmetique moussante ; utilisations pour le nettoyage ou le demaquillage